Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

NCT06489028 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Leg Ulcer

Interventions

DRUG: allo-APZ2-CVU
DRUG: Placebo

Sponsor

RHEACELL GmbH & Co. KG

Collaborators

[object Object]